Marrow Infiltrating Lymphocytes – Role in Biology and Cancer Therapy
The past several years have witnessed the acceptance of immunotherapy into the mainstream of therapeutics options for patients with various cancers. This has, in large part, been driven by the clinical successes of antibodies to the checkpoint inhibitors, CTLA-4 and PD-1, capable of imparting long-...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2016-03-01
|
| Series: | Frontiers in Immunology |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fimmu.2016.00112/full |